Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: Study on the Use of Lateral Decubitus Position in Left Breast Cancer Patients Undergoing Adjuvant Radiotherapy [NA]
A clinical trial update announcing ongoing recruitment for a study evaluating the use of the lateral decubitus position during adjuvant radi…
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: Adaptive Symptom Self-Management Immunotherapy Study [NA]
This clinical trial update from the University of Arizona describes an ongoing adaptive symptom self-management immunotherapy study that is …
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: Omitting Sentinel Node Procedure in Breast Cancer Patients Undergoing Breast Conserving Therapy [NA]
A clinical trial is evaluating omitting the sentinel lymph node procedure in breast cancer patients undergoing breast-conserving therapy. Th…
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: Auricular Acupressure for Sleep Disorder Prevention in Breast Cancer [NA]
A clinical trial is evaluating auricular acupressure to prevent sleep disturbances in people with breast cancer. The study is not yet recrui…
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias [Phase 2]
Phase 2 clinical trial evaluating cannabidiol for aromatase inhibitor-associated arthralgia in breast cancer patients has completed, with re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) [Phase 3]
An update on the Phase 3 DESTINY-Breast05 trial comparing trastuzumab deruxtecan (Enhertu) with trastuzumab emtansine (Kadcyla) in high-risk…
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer [Phase 3]
Phase 3 randomized study comparing TH versus THL as first-line therapy for HER2-positive metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer [Phase 1, Phase 2]
Clinical trial evaluating elacestrant in combination with onapristone in advanced or metastatic breast cancer has been terminated (Phase 1/P…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP] [Phase 2]
A Phase 2 neoadjuvant trial evaluating pembrolizumab with HER2-targeted therapy for HER2-positive breast cancer, with results posted in May …
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial [Phase 3]
A Phase 3 clinical trial evaluating fertility preservation using tamoxifen and letrozole in estrogen-sensitive tumors is currently recruitin…
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Predicting Cancer Risk With Digital and Molecular Markers [NA]
A University of Erlangen-Nürnberg Medical School trial aims to predict cancer risk using digital and molecular markers across several cancer…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in Brazil
A real-world study evaluating trastuzumab-deruxtecan in triple-negative metastatic HER2-low breast cancer conducted in Brazil has been termi…
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: 18F-fluoroestradiol (18F-FES) PET/CT Guided First-line Treatment for HR+/HER2- Metastatic Breast Cancer Patients
A clinical trial evaluating 18F-FES PET/CT guided first-line treatment for HR+/HER2- metastatic breast cancer has completed.
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies. [Phase 2]
Phase 2 clinical trial evaluating whether infrared laser spectroscopy analysis of liquid biopsies can predict the efficacy of palbociclib in…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma [NA]
This clinical trial compares single-fraction accelerated partial breast irradiation to five-fraction accelerated partial breast irradiation …
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: Topical Calcipotriene Treatment for Breast Cancer Immunoprevention [Phase 1]
Phase 1 trial evaluating topical calcipotriene for breast cancer immunoprevention has been terminated.
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: NeoRad Breast Cancer Study [Phase 3]
A Phase 3 clinical trial called NeoRad for breast cancer is currently recruiting, sponsored by Bielefeld University.
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life Outcomes
This clinical trial update notes an active-but-not-recruiting study by Henry Ford Health System evaluating satisfaction and health-related q…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: Developing Breast (Cancer) Organoids
A Maastricht Radiation Oncology-sponsored clinical trial is recruiting to develop organoid models for breast cancer.
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: Comparing Decision on Aesthetics After Breast Cancer Locoregional Treatment. [NA]
The document provides an update on a clinical trial evaluating aesthetics after locoregional breast cancer treatment, sponsored by Fundação …
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: A Study to Evaluate Safety, Tolerability, Dosimetry, and Preliminary Efficacy of the HER2 Directed Radioligand CAM-H2 in Patients With Advanced/Metastatic HER2-Positive Breast, Gastric, and Gastro-Esophageal Junction (GEJ) Cancer [Phase 1, Phase 2]
A phase 1/2 study evaluating CAM-H2, a HER2-directed radioligand, in advanced/metastatic HER2-positive breast, gastric, and gastroesophageal…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Influence of Preoperative Vitamin D Level on Postoperative Pain in Breast Cancer Surgery Patients
A completed clinical trial examining whether preoperative vitamin D status affects postoperative pain after breast cancer surgery.
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: A Study of PF-07260437 in Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 study of PF-07260437 in advanced or metastatic solid tumors was terminated, with results posted on 2025-05-06.
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Investigation of the Effect of Erector Spinae Plane Block on Systemic Immuno-Inflammatory Index [NA]
The study NCT06954324 completed an evaluation of whether an erector spinae plane block influences the systemic immune-inflammatory index in …
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI's Pan-tumor Priority Study is an observational cancer study that is currently active but not recruiting.